Ginkgo biloba-Extract EGb 761® improves neuropsychiatric symptoms of dementia. Overview of randomised controlled trials
R Ihl, R Hoerr · Zeitschrift für Phytotherapie · 2009 · Heft 08
Bibliografische Angaben
Zusammenfassung
In previous studies, EGb 761® improved behavioural and psychological symptoms in patients with mild aging-associated cognitive impairment. Findings from subgroup analyses of dementia trials suggested that EGb 761® may be more effective in patients who suffer from neuropsychiatric symptoms. Patients with mild to moderate dementia associated with neuropsychiatric symptoms were therefore enrolled in three recent randomised, controlled, double-blind, clinical trials. Two trials were placebo-controlled (trial 1: 395 patients; trial 2: 404 patients), one trial was reference-controlled (trial 3: 93 patients). Patients…